The ROE as of December 2024 (TTM) for Manhattan Scientifics, Inc. (MHTX) is 47.28%

According to Manhattan Scientifics, Inc.’s latest financial reports and current stock price. The company's current ROE is 47.28%. This represents a change of 290.85% compared to the average of 12.10% of the last 4 quarters.

Manhattan Scientifics, Inc. (MHTX) Historical ROE (quarterly & annually)

How has MHTX ROE performed in the past?

The mean historical ROE of Manhattan Scientifics, Inc. over the last ten years is 610.69%. The current 47.28% ROE has changed -92.26% with respect to the historical average. Over the past ten years (40 quarters), MHTX's ROE was at its highest in in the December 2018 quarter at 2.41%. The ROE was at its lowest in in the March 2022 quarter at -286.34%.

Manhattan Scientifics, Inc. (MHTX) ROE by Quarter and Year

Discovering the peaks and valleys of Manhattan Scientifics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Manhattan Scientifics, Inc. (MHTX) Average ROE

How has MHTX ROE performed in the past?

The current ROE of Manhattan Scientifics, Inc. (MHTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Manhattan Scientifics, Inc. (MHTX) ROE vs. Peers

How is MHTX’s ROE compared to its peers?

Manhattan Scientifics, Inc.’s ROE is less than VentriPoint Diagnostics Ltd. (388.60%), greater than Cannabix Technologies Inc. (-78.37%), less than Accelerate Diagnostics, Inc. (165.71%), less than Venus Concept Inc. (884.09%), less than Nemaura Medical Inc. (37.24%), greater than Bluejay Diagnostics, Inc. (-155.68%), greater than Movano Inc. (-345.78%), less than INVO Bioscience, Inc. (0%), greater than enVVeno Medical Corporation (-48.73%), less than OpGen, Inc. (120.18%), greater than Biomerica, Inc. (-84.62%), less than BIOLASE, Inc. (12.27%), less than Semler Scientific, Inc. (20.31%), greater than NanoVibronix, Inc. (-101.17%), greater than Asensus Surgical, Inc. (-406.97%), less than DexCom, Inc. (31.20%), greater than Tandem Diabetes Care, Inc. (-49.32%), greater than Pacific Biosciences of California, Inc. (-68.68%), greater than Nano-X Imaging Ltd. (-27.63%),

Build a custom stock screener for Manhattan Scientifics, Inc. (MHTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Manhattan Scientifics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Manhattan Scientifics, Inc. (MHTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Manhattan Scientifics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.